Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China.
Department of Endocrinology, The First Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang 310000, P.R. China.
Mol Med Rep. 2017 Dec;16(6):8709-8720. doi: 10.3892/mmr.2017.7726. Epub 2017 Oct 4.
Accumulated evidence has indicated that micro (mi)RNAs play vital roles in the occurrence and development of human muscle invasive bladder cancer (MIBC), however, little is known about the miRNAs' regulatory networks. In the present study, the authors aimed to use bioinformatics analysis to identify the key miRNAs and potential target genes, as well as studying the underlying mechanisms for MIBC. They collected several human MIBC tissues to generate a miRNA expression analysis by microarray analysis comparing with normal bladder tissues, identifying 104 differentially expressed miRNAs (102 were downregulated and 2 were upregulated) and predicted 11,884 putative target genes of the dysregulated miRNAs. To understand the function of dysregulated miRNAs in the development of MIBC, networks among miRNAs and genes, gene ontologies and pathways were built. The subsequent bioinformatics analysis indicated that the mitogen‑associated protein kinase (MAPK) signaling pathway, apoptosis and pathways in cancer and the cell cycle, were significantly enriched Overall, these results provided comprehensive information on the biological function of dysregulated miRNAs in the development of MIBC. The identification of miRNAs and their putative targets may offer new diagnostic and therapeutic strategies for human muscle invasive bladder cancer.
已有大量证据表明,微小 RNA(miRNA)在人类浸润性膀胱癌(MIBC)的发生和发展中起着至关重要的作用,然而,miRNA 的调控网络知之甚少。在本研究中,作者旨在通过生物信息学分析鉴定关键 miRNA 和潜在的靶基因,并研究 MIBC 的潜在机制。他们收集了几个人类 MIBC 组织,通过与正常膀胱组织的微阵列分析进行 miRNA 表达分析,鉴定出 104 个差异表达的 miRNA(102 个下调,2 个上调),并预测了失调 miRNA 的 11884 个潜在靶基因。为了了解失调 miRNA 在 MIBC 发展中的作用,构建了 miRNA 和基因之间的网络、基因本体论和途径。随后的生物信息学分析表明,丝裂原相关蛋白激酶(MAPK)信号通路、细胞凋亡和癌症途径以及细胞周期明显富集。综上所述,这些结果提供了失调 miRNA 在 MIBC 发展中的生物学功能的全面信息。miRNA 及其潜在靶标的鉴定可能为人类浸润性膀胱癌提供新的诊断和治疗策略。